Detalhe da pesquisa
1.
Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network.
J Oncol Pharm Pract
; 29(8): 1907-1914, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36803319
2.
Description of the role of pharmacist independent double checks during cognitive order verification of outpatient parenteral anti-cancer therapy.
J Oncol Pharm Pract
; 28(2): 381-386, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33611975
3.
Describing the role of the hematology/oncology clinical pharmacist in health information technology.
J Oncol Pharm Pract
; 27(1): 14-19, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32306889
4.
Development of a tool to allocate inpatient specialized pharmacy resources at a comprehensive cancer center.
J Oncol Pharm Pract
; 26(7): 1686-1694, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32865162
5.
The pharmacist's role in chimeric antigen receptor T cell therapy.
J Oncol Pharm Pract
; 26(7): 1725-1731, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32819199